• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Olema Oncology To Unveil OP-3136 Clinical Data At 2026 ASCO

    GLOBENEWSWIRE

    Olema Oncology Unveils Palazestrant, OP-3136 Preclinical Data

    FIRSTWORD PHARMA

    Olema Oncology Issues Inducement Grants Under Nasdaq Rule

    GLOBENEWSWIRE

    Olema Oncology to Present Palazestrant, OP-3136 Data in 2026

    GLOBENEWSWIRE

    Olema Oncology Reveals 2025 Financial Results

    GLOBENEWSWIRE

    Olema Oncology Issues Inducement Grants Under Nasdaq Rules

    GLOBENEWSWIRE

    Olema Oncology To Present At TD Cowen Health Care Conference

    GLOBENEWSWIRE

    Olema Oncology Reports Inducement Awards Under Nasdaq Rule

    GLOBENEWSWIRE

    Olema Oncology Cfo And Coo Departure Announced

    GLOBENEWSWIRE

    Olema Oncology To Present At J.P. Morgan Healthcare Conference

    GLOBENEWSWIRE

    Olema Oncology Issues Inducement Grants Under Nasdaq Rules

    GLOBENEWSWIRE

    Olema Oncology Reports Inducement Grants Under Nasdaq Rules

    GLOBENEWSWIRE

    Olema Oncology Joins 8Th Evercore Healthcare Conference

    GLOBENEWSWIRE

    Olema Oncology Closes $218.5M Public Offering

    GLOBENEWSWIRE

    Olema Oncology Prices $190M Public Stock Offering

    GLOBENEWSWIRE

    Olema Oncology Announces Stock and Pre-Funded Warrant Offering

    GLOBENEWSWIRE

    Olema Oncology To Participate In Upcoming Investor Conferences

    GLOBENEWSWIRE

    Olema to Present Ph3 OPERA-02 Trial of Palazestrant at SABCS 2025

    GLOBENEWSWIRE

    Olema Oncology Unveils Phase 1B/2 Palazestrant + Ribociclib Data

    GLOBENEWSWIRE

    Olema Oncology, Pfizer Partner to Combine Palazestrant

    GLOBENEWSWIRE

    Olema Oncology issues inducement grants per Nasdaq Listing Rule

    GLOBENEWSWIRE

    Olema Appoints Oncology Biotech Executive Scott Garland to Board of Directors

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.